Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tingyou Li

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|July 14, 2007
[N-allyl-Dmt1]-endomorphins are micro-opioid receptor antagonists lacking inverse agonist propertiesEwa D Marczak, Yunden Jinsmaa, Tingyou Li, et al.
Bioorganic & Medicinal Chemistry|March 8, 2014
[Dmt(1)]DALDA analogues with enhanced μ opioid agonist potency and with a mixed μ/κ opioid activity profileLongxiang Bai, Ziyuan Li, Jiajia Chen, et al.
Chemical Biology & Drug Design|June 12, 2020
Novel µ opioid antagonists derived from the µ opioid agonists endomorphin and [Dmt<sup>1</sup> ]DALDA (H-Dmt-D-Arg-Phe-Lys-NH<sub>2</sub> )Saijian Shi, Jian Xu, LingLing Feng, et al.
Bioorganic & Medicinal Chemistry Letters|September 5, 2006
Synthesis of 3,6-bis[H-Tyr/H-Dmt-NH(CH2)m,n]-2(1H)pyrazinone derivatives: function of alkyl chain length on opioid activityKimitaka Shiotani, Tingyou Li, Anna Miyazaki, et al.
Chemical & Pharmaceutical Bulletin|September 6, 2005
Studies on the mechanism of 1,2-dihydropyrazin-2-one ring formation from dipeptidyl chloromethyl ketone and its chemical properties: immediate deamination during catalytic hydrogenationAnna Miyazaki, Yutaka Fujisawa, Kimitaka Shiotani, et al.
Journal of Medicinal Chemistry|January 22, 2005
Development of potent mu-opioid receptor ligands using unique tyrosine analogues of endomorphin-2Tingyou Li, Yoshio Fujita, Yuko Tsuda, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2007
Design and synthesis of opioidmimetics containing 2',6'-dimethyl-L-tyrosine and a pyrazinone-ring platformKimitaka Shiotani, Tingyou Li, Anna Miyazaki, et al.
Journal of Medicinal Chemistry|March 11, 2026
Systematic Exploration of the Potential of HPQ as the Core Scaffold of Probes for in Vivo Imaging: A Case Study of FAP-Responsive ProbesYan Hu, Xiaowei Feng, Jiang Wu, et al.
Bioorganic & Medicinal Chemistry|April 3, 2003
Structural studies of [2',6'-dimethyl-L-tyrosine1]endomorphin-2 analogues: enhanced activity and cis orientation of the Dmt-Pro amide bondYoshio Okada, Yoshio Fujita, Takashi Motoyama, et al.
European Journal of Pharmacology|February 17, 2005
Differentiation of opioid receptor preference by [Dmt1]endomorphin-2-mediated antinociception in the mouseYunden Jinsmaa, Yoshio Fujita, Kimitaka Shiotani, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
The Journal of Pharmacology and Experimental Therapeutics|July 14, 2007
[N-allyl-Dmt1]-endomorphins are micro-opioid receptor antagonists lacking inverse agonist propertiesEwa D Marczak, Yunden Jinsmaa, Tingyou Li, et al.
Bioorganic & Medicinal Chemistry|March 8, 2014
[Dmt(1)]DALDA analogues with enhanced μ opioid agonist potency and with a mixed μ/κ opioid activity profileLongxiang Bai, Ziyuan Li, Jiajia Chen, et al.
Chemical Biology & Drug Design|June 12, 2020
Novel µ opioid antagonists derived from the µ opioid agonists endomorphin and [Dmt<sup>1</sup> ]DALDA (H-Dmt-D-Arg-Phe-Lys-NH<sub>2</sub> )Saijian Shi, Jian Xu, LingLing Feng, et al.
Bioorganic & Medicinal Chemistry Letters|September 5, 2006
Synthesis of 3,6-bis[H-Tyr/H-Dmt-NH(CH2)m,n]-2(1H)pyrazinone derivatives: function of alkyl chain length on opioid activityKimitaka Shiotani, Tingyou Li, Anna Miyazaki, et al.
Chemical & Pharmaceutical Bulletin|September 6, 2005
Studies on the mechanism of 1,2-dihydropyrazin-2-one ring formation from dipeptidyl chloromethyl ketone and its chemical properties: immediate deamination during catalytic hydrogenationAnna Miyazaki, Yutaka Fujisawa, Kimitaka Shiotani, et al.
Journal of Medicinal Chemistry|January 22, 2005
Development of potent mu-opioid receptor ligands using unique tyrosine analogues of endomorphin-2Tingyou Li, Yoshio Fujita, Yuko Tsuda, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2007
Design and synthesis of opioidmimetics containing 2',6'-dimethyl-L-tyrosine and a pyrazinone-ring platformKimitaka Shiotani, Tingyou Li, Anna Miyazaki, et al.
Journal of Medicinal Chemistry|March 11, 2026
Systematic Exploration of the Potential of HPQ as the Core Scaffold of Probes for in Vivo Imaging: A Case Study of FAP-Responsive ProbesYan Hu, Xiaowei Feng, Jiang Wu, et al.
Bioorganic & Medicinal Chemistry|April 3, 2003
Structural studies of [2',6'-dimethyl-L-tyrosine1]endomorphin-2 analogues: enhanced activity and cis orientation of the Dmt-Pro amide bondYoshio Okada, Yoshio Fujita, Takashi Motoyama, et al.
European Journal of Pharmacology|February 17, 2005
Differentiation of opioid receptor preference by [Dmt1]endomorphin-2-mediated antinociception in the mouseYunden Jinsmaa, Yoshio Fujita, Kimitaka Shiotani, et al.
Pageof 4